Search results
About Those New Vanguard Fees: Allan Roth
etf.com via Yahoo Finance· 23 hours agoClass action service fee: A fee of 20% will be deducted from these recovered funds prior to their deposit into your brokerage account. Foreign securities...
Druckenmiller says he bought five Argentinian stocks, praises Javier Milei's policies
CNBC· 2 days agoBillionaire investor Stanley Druckenmiller said Tuesday that he has been finding ways to invest in...
Novo Nordisk Sets Sights on a Long-Lasting Successor to Its Weight Loss Blockbuster
Barrons.com· 6 hours agoNovo’s American depositary receipts are up 50% over the past 12 months. The new research effort...
Teva Pharmaceutical’s stock climbs as schizophrenia treatment shows promise
Market Watch· 1 day agoTeva Pharmaceutical Industries stock jumped more than 6% early Wednesday after the company reported...
Anheuser-Busch Stock Rallies On Earnings, But Boycott Pain Persists
Investor's Business Daily· 22 hours agoAnheuser-Busch Stock Anheuser-Busch is primarily listed on the Euronext exchange under the ticker...
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 3 days agoAmerican depositary receipts (ADRs) of BioNTech (BNTX) were down less than 1% in intraday trading...
Axxcess Wealth Management LLC Purchases New Position in Invesco China Technology ETF (NYSEARCA:CQQQ)
ETF DAILY NEWS· 11 hours agoAxxcess Wealth Management LLC acquired a new stake in shares of Invesco China Technology ETF (NYSEARCA:CQQQ – Free Report) in the fourth quarter, according to the company in its most recent ...
AB InBev Is Moving Past the Bud Light Controversy
The Wall Street Journal· 1 day agoGlobal brewing company Anheuser-Busch InBev posted solid results, underscoring the fading impact of last year’s Bud Light boycotts. Total worldwide...
Stocks to Watch Monday: Li Auto, Perficient, Apple, Boeing
The Wall Street Journal· 3 days ago**Li Auto (LI)**: The Chinese electric-vehicle maker posted strong orders for its cheaper model. Its...
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 3 days agoFor 2024, BioNTech reiterated its revenue guidance of €2.5 billion to €3.1 billion. American ...
